Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension

DRUG2 trials

Sponsors

Alcon Research

Conditions

GlaucomaOcular HypertensionOpen-Angle Glaucoma

Phase 4

SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

CompletedNCT02419508

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2015-08-07End: 2018-02-27Updated: 2018-11-15

24-hr Intraocular Pressure Control With SIMBRINZA ®

CompletedNCT02770248

Alcon ResearchGlaucoma

Start: 2016-05-23End: 2017-01-14Updated: 2018-07-02